{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T10:50:13Z","timestamp":1786445413465,"version":"build-2736575974"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1097\/iop.0b013e31802d9802","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T04:23:01Z","timestamp":1168402981000},"page":"65-66","source":"Crossref","is-referenced-by-count":46,"title":["Erlotinib-Associated Trichomegaly"],"prefix":"10.1097","volume":"23","author":[{"given":"Katherine","family":"Lane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-19-20210129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1470-2045(05)70243-6","article-title":"Cutaneous side-effects of kinase inhibitors and blocking antibodies..","volume":"6","author":"Robert","year":"2005","journal-title":"Lancet Oncol"},{"key":"R4-19-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/02841860310006038","article-title":"EGFR inhibition induces trichomegaly.","volume":"42","author":"Dueland","year":"2003","journal-title":"Acta Oncol"},{"key":"R5-19-20210129","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1365-2133.2004.06265.x","article-title":"Trichomegaly following treatment with gefitinib (ZD1839).","volume":"151","author":"Pascual","year":"2004","journal-title":"Br J Dermatol"},{"key":"R6-19-20210129","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/annonc\/mdi300","article-title":"Trichomegaly of the eyelashes following treatment with cetuximab.","volume":"16","author":"Bouch\u00e9","year":"2005","journal-title":"Ann Oncol"},{"key":"R7-19-20210129","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1200\/JCO.2001.19.13.3267","article-title":"Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies.","volume":"19","author":"Hidalgo","year":"2001","journal-title":"J Clin Oncol"}],"container-title":["Ophthalmic Plastic & Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IOP.0b013e31802d9802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:17:53Z","timestamp":1786033073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002341-200701000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/iop.0b013e31802d9802","relation":{},"ISSN":["0740-9303"],"issn-type":[{"value":"0740-9303","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}